Sorafenib tosylate

Product name: Sorafenib tosylate
CBNumber: CB92131200
Formula: C21H16ClF3N4O3.C7H8SO3
Molecular Weight: 637.03
Description:
Toluenesulfonic Sorafenib is a novel multi-target anticancer drugs, developed by the German pharmaceutical company Bayer is successful, can act simultaneously on tumor cells and tumor vasculature. It has a dual anti-tumor effects: either by blocking the RAF / MEK / ERK-mediated cell signaling pathways and direct inhibition of tumor cell proliferation, but also by inhibiting VEGF and platelet-derived growth factor (PDGF) receptor blocking tumor angiogenesis indirectly inhibit the growth of tumor cells.